REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 19 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $18,994,935 | +7020.5% | 15,400,000 | +5210.3% | 0.00% | – |
| Q4 2022 | $266,764 | -86.0% | 290,000 | -83.4% | 0.00% | – |
| Q3 2022 | $1,899,000 | -91.6% | 1,750,000 | -92.6% | 0.00% | -100.0% |
| Q1 2022 | $22,500,000 | -67.5% | 23,546,000 | -69.9% | 0.01% | -64.3% |
| Q4 2021 | $69,333,000 | -51.8% | 78,204,000 | -37.4% | 0.01% | -53.3% |
| Q3 2021 | $143,872,000 | +17.8% | 124,954,000 | +19.8% | 0.03% | +11.1% |
| Q2 2021 | $122,081,000 | +3.9% | 104,329,000 | 0.0% | 0.03% | -6.9% |
| Q1 2021 | $117,539,000 | – | 104,329,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antara Capital LP | 49,500,000 | $47,535,000 | 1.45% |
| ZAZOVE ASSOCIATES LLC | 16,238,000 | $15,254,000 | 1.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 26,000,000 | $24,456,000 | 0.22% |
| WEDBUSH SECURITIES INC | 30,000 | $2,807,000 | 0.13% |
| AVIVA PLC | 15,000,000 | $14,034,000 | 0.07% |
| Context Capital Management, LLC | 1,000 | $951,000 | 0.06% |
| LMR Partners LLP | 4,500,000 | $4,242,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,500,000 | $14,580,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 27,770,000 | $26,121,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $45,150,000 | 0.02% |